Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell adhesion is the process by which cells interact and attach to neighboring cells or the extracellular matrix (ECM) via specialized transmembrane proteins called cell adhesion molecules, including integrins, cadherins, selectins, and the immunoglobulin superfamily[2][3][4]. Cell motility describes the movement of cells and is tightly interconnected with adhesion, as cells must adhere and de-adhere in a coordinated manner to migrate through tissues[4]. These processes are essential for tissue development, maintenance, wound healing, immune cell trafficking, and morphogenesis[1][2][4]. Dysregulation of adhesion and motility underlies pathological states such as cancer metastasis, chronic inflammation, and impaired tissue repair[1][3]. For structured data or drug discovery purposes, it is essential to specify the individual molecules involved (e.g., "Integrin beta-1", "E-selectin", "Cadherin-1") rather than broad process terms like "Cell adhesion and motility", which do not refer to a unique, actionable target for therapeutic intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell adhesion and motility.